Profil
Helena Pozios was the founder of Bouche B Sprl, founded in 2015, and held the title of Chief Executive Officer from 2015 to 2020.
Current jobs include Director at Antigon SA since 2022; Head- Venture Capital at Sambrinvest SA since 2019; Board Member at Tools4patient SA since 2019; Member of the Investment Committee at Innovation Fund (BE) since 2019; Member of the Investment Committee at Theodorus Investment Funds since 2019; Board Member at Lys Medical SRL since 2020; Board Member at Spentys SA since 2020; Board Member at InhaTarget Therapeutics SRL since 2020; Board Member at ConvEyXo SA since 2020; and Board Member at Brussels South Charleroi.
BioPark Dev SA since 2019.
Education history includes a graduate degree from ESSEC Business School conferred in 2005 and an undergraduate degree from Université Paris-Saclay conferred in 2001.
Postes actifs de Helena Pozios
| Sociétés | Poste | Début |
|---|---|---|
Sambrinvest SA
Sambrinvest SA Investment ManagersFinance Sambrinvest invests in companies located in Charleroi region. The firm focuses on industry, materials, food industry and life sciences. It participates in the form of debt and equity for early stage capital transactions. | Directeur en chef des Investissements | - |
Tools4patient SA
Tools4patient SA Packaged SoftwareTechnology Services Develops and commercializes clinical development analytical tools to pharmaceutical & biotechnology companies | Directeur/Membre du Conseil | 01/04/2019 |
Theodorus Investment Funds
Theodorus Investment Funds Investment ManagersFinance Theodorus invests in companies located in Belgium. The firm targets companies operating in the fields of biotech, medtech, digital and engineering applications. It provides financing for seed and early stage capital requirements with an investments size ranging from EUR 0.25 to 2.5 million. It also acts as a lead investor. | Private Equity Investor | 01/01/2019 |
Innovation Fund (BE)
Innovation Fund (BE) Investment ManagersFinance Innovation Fund invests in companies located in Belgium. The firm targets companies operating in the fields of process technology, material science, hygiene & cosmetology, bio-sciences, recycling technology and chemical sector. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 0.25 - 0.75 million. | Private Equity Investor | 01/01/2019 |
ConvEyXo SA
ConvEyXo SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company focused develops therapeutic power of RNA-enhanced exosomes | Directeur/Membre du Conseil | 01/01/2020 |
Inhatarget Therapeutics
Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Develops drugs for cancer and chronic diseases | Directeur/Membre du Conseil | 01/01/2020 |
Lys Medical SRL
Lys Medical SRL Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Directeur/Membre du Conseil | 01/01/2020 |
Spentys SA
Spentys SA Medical SpecialtiesHealth Technology Develops orthopaedic immobilization devices | Directeur/Membre du Conseil | 01/01/2020 |
ANTIGON SA
ANTIGON SA Medical SpecialtiesHealth Technology Develops, manufactures and supplies blood safety transfusion device | Directeur/Membre du Conseil | 14/06/2022 |
| ░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Helena Pozios
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Helena Pozios
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
ESSEC Business School
ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sambrinvest SA
Sambrinvest SA Investment ManagersFinance Sambrinvest invests in companies located in Charleroi region. The firm focuses on industry, materials, food industry and life sciences. It participates in the form of debt and equity for early stage capital transactions. | Finance |
ANTIGON SA
ANTIGON SA Medical SpecialtiesHealth Technology Develops, manufactures and supplies blood safety transfusion device | Health Technology |
Tools4patient SA
Tools4patient SA Packaged SoftwareTechnology Services Develops and commercializes clinical development analytical tools to pharmaceutical & biotechnology companies | Technology Services |
Innovation Fund (BE)
Innovation Fund (BE) Investment ManagersFinance Innovation Fund invests in companies located in Belgium. The firm targets companies operating in the fields of process technology, material science, hygiene & cosmetology, bio-sciences, recycling technology and chemical sector. It provides financing for seed and early stage capital requirements with an investment size ranging between EUR 0.25 - 0.75 million. | Finance |
Theodorus Investment Funds
Theodorus Investment Funds Investment ManagersFinance Theodorus invests in companies located in Belgium. The firm targets companies operating in the fields of biotech, medtech, digital and engineering applications. It provides financing for seed and early stage capital requirements with an investments size ranging from EUR 0.25 to 2.5 million. It also acts as a lead investor. | Finance |
Lys Medical SRL
Lys Medical SRL Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Spentys SA
Spentys SA Medical SpecialtiesHealth Technology Develops orthopaedic immobilization devices | Health Technology |
Université Paris-Saclay
Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhatarget Therapeutics
Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Develops drugs for cancer and chronic diseases | Health Technology |
ConvEyXo SA
ConvEyXo SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company focused develops therapeutic power of RNA-enhanced exosomes | Commercial Services |
Brussels South Charleroi BioPark Dev SA | |
Bouche B Sprl |
















